Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease.
| Image |  |
|---|---|
| Description | scientific article published on 12 May 2015 |
| Author/s |
author: Daniel A. Llano |
| Publication date | July 1, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |